These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 32068525

  • 1. Molecular epidemiology, in vitro susceptibility and exoenzyme screening of Malassezia clinical isolates.
    Li W, Zhang ZW, Luo Y, Liang N, Pi XX, Fan YM.
    J Med Microbiol; 2020 Mar; 69(3):436-442. PubMed ID: 32068525
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology and susceptibility profile to classic antifungals and over-the-counter products of Malassezia clinical isolates from a Portuguese University Hospital: a prospective study.
    Pedrosa AF, Lisboa C, Faria-Ramos I, Silva R, Ricardo E, Teixeira-Santos R, Miranda I, Rodrigues AG.
    J Med Microbiol; 2019 May; 68(5):778-784. PubMed ID: 30907722
    [Abstract] [Full Text] [Related]

  • 3. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine.
    Gupta AK, Kohli Y, Li A, Faergemann J, Summerbell RC.
    Br J Dermatol; 2000 Apr; 142(4):758-65. PubMed ID: 10792228
    [Abstract] [Full Text] [Related]

  • 4. Antifungal activities of azole agents against the Malassezia species.
    Miranda KC, de Araujo CR, Costa CR, Passos XS, de Fátima Lisboa Fernandes O, do Rosário Rodrigues Silva M.
    Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
    [Abstract] [Full Text] [Related]

  • 5. [In vitro activity of ketoconazole, itraconazole and terbinafine against Malassezia strains isolated from neonates].
    Sancak B, Ayhan M, Karaduman A, Arikan S.
    Mikrobiyol Bul; 2005 Jul; 39(3):301-8. PubMed ID: 16358489
    [Abstract] [Full Text] [Related]

  • 6. [In vitro antifungal activity of azoles and amphotericin B against Malassezia furfur by the CLSI M27-A3 microdilution and Etest® methods].
    Galvis-Marín JC, Rodríguez-Bocanegra MX, Pulido-Villamarín ADP, Castañeda-Salazar R, Celis-Ramírez AM, Linares-Linares MY.
    Rev Iberoam Micol; 2017 Jul; 34(2):89-93. PubMed ID: 28214276
    [Abstract] [Full Text] [Related]

  • 7. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method.
    Rojas FD, Sosa Mde L, Fernández MS, Cattana ME, Córdoba SB, Giusiano GE.
    Med Mycol; 2014 Aug; 52(6):641-6. PubMed ID: 24965946
    [Abstract] [Full Text] [Related]

  • 8. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
    Cafarchia C, Figueredo LA, Iatta R, Montagna MT, Otranto D.
    Vet Microbiol; 2012 Mar 23; 155(2-4):395-8. PubMed ID: 21962411
    [Abstract] [Full Text] [Related]

  • 9. Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants.
    Rhimi W, Chebil W, Ugochukwu ICI, Babba H, Otranto D, Cafarchia C.
    Med Mycol; 2022 Dec 29; 61(1):. PubMed ID: 36626926
    [Abstract] [Full Text] [Related]

  • 10. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
    Cafarchia C, Iatta R, Immediato D, Puttilli MR, Otranto D.
    Med Mycol; 2015 Sep 29; 53(7):743-8. PubMed ID: 26162472
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest.
    Velegraki A, Alexopoulos EC, Kritikou S, Gaitanis G.
    J Clin Microbiol; 2004 Aug 29; 42(8):3589-93. PubMed ID: 15297502
    [Abstract] [Full Text] [Related]

  • 13. Malassezia species in healthy skin and in dermatological conditions.
    Prohic A, Jovovic Sadikovic T, Krupalija-Fazlic M, Kuskunovic-Vlahovljak S.
    Int J Dermatol; 2016 May 29; 55(5):494-504. PubMed ID: 26710919
    [Abstract] [Full Text] [Related]

  • 14. Epidemiological characteristics of Malassezia folliculitis and use of the May-Grünwald-Giemsa stain to diagnose the infection.
    Durdu M, Güran M, Ilkit M.
    Diagn Microbiol Infect Dis; 2013 Aug 29; 76(4):450-7. PubMed ID: 23706503
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species.
    Carrillo-Muñoz AJ, Rojas F, Tur-Tur C, de Los Ángeles Sosa M, Diez GO, Espada CM, Payá MJ, Giusiano G.
    Mycoses; 2013 Sep 29; 56(5):571-5. PubMed ID: 23496653
    [Abstract] [Full Text] [Related]

  • 17. [Malassezia species isolated from skin diseases in a care center in the city of Buenos Aires, Argentina].
    Canteros CE, Soria M, Rivas C, Lee W, López Joffre MC, Rodero L, Perrotta D, Körte C, Davel G.
    Rev Argent Microbiol; 2003 Sep 29; 35(3):156-61. PubMed ID: 14587378
    [Abstract] [Full Text] [Related]

  • 18. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
    Jesus FP, Lautert C, Zanette RA, Mahl DL, Azevedo MI, Machado ML, Dutra V, Botton SA, Alves SH, Santurio JM.
    Vet Microbiol; 2011 Aug 26; 152(1-2):161-4. PubMed ID: 21658868
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility of Malassezia furfur against azole compounds.
    Schmidt A, Rühl-Hörster B.
    Mycoses; 1996 Aug 26; 39(7-8):309-12. PubMed ID: 9009652
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species.
    Uchida K, Nishiyama Y, Tanaka T, Yamaguchi H.
    Int J Antimicrob Agents; 2003 Mar 26; 21(3):234-8. PubMed ID: 12636984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.